
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
ALDH2 as a potential stem cell-related biomarker in lung adenocarcinoma: Comprehensive multi-omics analysis
Thi-Oanh Tran, Thanh Hoa Vo, Luu Ho Thanh Lam, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 1921-1929
Open Access | Times Cited: 49
Thi-Oanh Tran, Thanh Hoa Vo, Luu Ho Thanh Lam, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 1921-1929
Open Access | Times Cited: 49
Showing 1-25 of 49 citing articles:
Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways
Maya R. MacLean, Olivia L. Walker, Raj Pranap Arun, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4102-4102
Open Access | Times Cited: 13
Maya R. MacLean, Olivia L. Walker, Raj Pranap Arun, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4102-4102
Open Access | Times Cited: 13
Multi-Omics Profiling Reveals Glycerolipid Metabolism-Associated Molecular Subtypes and Identifies ALDH2 as a Prognostic Biomarker in Pancreatic Cancer
Jifeng Liu, Shurong Ma, Dawei Deng, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 207-207
Open Access | Times Cited: 1
Jifeng Liu, Shurong Ma, Dawei Deng, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 207-207
Open Access | Times Cited: 1
Inhibition of UBA52 induces autophagy via EMC6 to suppress hepatocellular carcinoma tumorigenesis and progression
Li Tong, Xiaofei Zheng, Tianqi Wang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 5
Li Tong, Xiaofei Zheng, Tianqi Wang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 5
NIPAL1 as a prognostic biomarker associated with pancreatic adenocarcinoma progression and immune infiltration
Youlong Zhu, Zongze Qi, Shujing Zu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Youlong Zhu, Zongze Qi, Shujing Zu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Hyper-methylation of ABCG1 as an epigenetics biomarker in non-small cell lung cancer
Thi-Oanh Tran, Luu Ho Thanh Lam, Nguyen Quoc Khanh Le
Functional & Integrative Genomics (2023) Vol. 23, Iss. 3
Closed Access | Times Cited: 12
Thi-Oanh Tran, Luu Ho Thanh Lam, Nguyen Quoc Khanh Le
Functional & Integrative Genomics (2023) Vol. 23, Iss. 3
Closed Access | Times Cited: 12
ALDH2 is a novel biomarker and exerts an inhibitory effect on melanoma
Lei Hua, Jinfeng Liao, Xinyu Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Lei Hua, Jinfeng Liao, Xinyu Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Multi-Omics Analysis Reveals the IFI6 Gene as a Prognostic Indicator and Therapeutic Target in Esophageal Cancer
Nguyen-Kieu Viet-Nhi, Tran Minh Quan, Vu Cong Truc, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2691-2691
Open Access | Times Cited: 4
Nguyen-Kieu Viet-Nhi, Tran Minh Quan, Vu Cong Truc, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2691-2691
Open Access | Times Cited: 4
Impact of intermittent high-dose radon exposures on lung epithelial cells: proteomic analysis and biomarker identification
Phawinee Subsomwong, Chutima Kranrod, Yuna Sakai, et al.
Journal of Radiation Research (2025)
Open Access
Phawinee Subsomwong, Chutima Kranrod, Yuna Sakai, et al.
Journal of Radiation Research (2025)
Open Access
Multi-omics and single-cell sequencing analyses reveal the potential significance of circadian pathways in cancer therapy
Hao Lai, Xiaoyun Xiang, Xingqing Long, et al.
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 1-2, pp. 107-121
Closed Access | Times Cited: 2
Hao Lai, Xiaoyun Xiang, Xingqing Long, et al.
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 1-2, pp. 107-121
Closed Access | Times Cited: 2
tRF-29-79 regulates lung adenocarcinoma progression through mediating glutamine transporter SLC1A5
Yuanjian Shi, Zehao Pan, Yipeng Feng, et al.
Carcinogenesis (2024) Vol. 45, Iss. 6, pp. 409-423
Closed Access | Times Cited: 2
Yuanjian Shi, Zehao Pan, Yipeng Feng, et al.
Carcinogenesis (2024) Vol. 45, Iss. 6, pp. 409-423
Closed Access | Times Cited: 2
The association of genomic alterations with PD‐L1 expression in Chinese patients with EGFR /ALK wild‐type lung adenocarcinoma and potential predictive value of Hippo pathway mutations to immunotherapy
Fangfang Liu, X. Zhang, Mengyao Lu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Fangfang Liu, X. Zhang, Mengyao Lu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Depletion of CPNE7 sensitizes colorectal cancer to 5‐fluorouracil by downregulating ATG9B expression
W Xu, Yujie Tang, Yang Yang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 2
W Xu, Yujie Tang, Yang Yang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 2
A comprehensive prognostic and immune infiltration analysis of UBA1 in pan‐cancer: A computational analysis and in vitro experiments
Can Chen, Yiwei Li, Zhenzhen Chen, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 16
Open Access | Times Cited: 2
Can Chen, Yiwei Li, Zhenzhen Chen, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 16
Open Access | Times Cited: 2
Deciphering the role of tryptophan metabolism-associated genes ECHS1 and ALDH2 in gastric cancer: implications for tumor immunity and personalized therapy
Lexin Wang, Xue Zhou, Haisheng Yan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Lexin Wang, Xue Zhou, Haisheng Yan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Qin Yang, Xi Yong, Xiaoli Chen, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 19
Open Access | Times Cited: 2
Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer
Andreea Crintea, Anne-Marie Constantin, Alexandru Cătălin Motofelea, et al.
Journal of Functional Biomaterials (2023) Vol. 14, Iss. 9, pp. 466-466
Open Access | Times Cited: 5
Andreea Crintea, Anne-Marie Constantin, Alexandru Cătălin Motofelea, et al.
Journal of Functional Biomaterials (2023) Vol. 14, Iss. 9, pp. 466-466
Open Access | Times Cited: 5
A novel disulfidptosis-related gene signature predicts overall survival of glioblastoma patients
Yuxia Zhang, Bing Liu, Y.-H. Zhou
Future Science OA (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Yuxia Zhang, Bing Liu, Y.-H. Zhou
Future Science OA (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Coactosin-Like Protein 1 (COTL1) Could Be an Immunological and Prognostic Biomarker: From Pan-Cancer Analysis to Low-Grade Glioma Validation
Xiaoyun Wang, Yuwei Bai, Bei Wang
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 1805-1820
Open Access | Times Cited: 1
Xiaoyun Wang, Yuwei Bai, Bei Wang
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 1805-1820
Open Access | Times Cited: 1
Three Liquid-Liquid Phase Separation-Related Genes Associated with Prognosis in Glioma
Ling Lv, Xin Zhang, Yajun Liu, et al.
Pharmacogenomics and Personalized Medicine (2024) Vol. Volume 17, pp. 171-181
Open Access | Times Cited: 1
Ling Lv, Xin Zhang, Yajun Liu, et al.
Pharmacogenomics and Personalized Medicine (2024) Vol. Volume 17, pp. 171-181
Open Access | Times Cited: 1
IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma
Jiannan Hu, Chuan-Jing Dai, Zhaoji Ding, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Jiannan Hu, Chuan-Jing Dai, Zhaoji Ding, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Identifying potential therapeutic targets in lung adenocarcinoma: a multi-omics approach integrating bulk and single-cell RNA sequencing with Mendelian randomization
You‐Peng Chen, Enzhong Li, Zhenglin Chang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
You‐Peng Chen, Enzhong Li, Zhenglin Chang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Identification of chemoresistance targets in doxorubicin-resistant lung adenocarcinoma cells using LC-MS/MS-based proteomics
Nuzhat Bano, KM Kainat, Mohammad Imran Ansari, et al.
Journal of Chemotherapy (2024), pp. 1-15
Closed Access | Times Cited: 1
Nuzhat Bano, KM Kainat, Mohammad Imran Ansari, et al.
Journal of Chemotherapy (2024), pp. 1-15
Closed Access | Times Cited: 1
Key Cell-in-Cell Related Genes are Identified by Bioinformatics and Experiments in Glioblastoma
Zhang Feng-lin, Jingliang Ye, Junle Zhu, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 1109-1130
Open Access | Times Cited: 1
Zhang Feng-lin, Jingliang Ye, Junle Zhu, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 1109-1130
Open Access | Times Cited: 1
ALDH2 mediates the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on improving cardiac remodeling
Han Liu, Bin Jiang, Rui Hua, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Han Liu, Bin Jiang, Rui Hua, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Identification of ALDH7A1 as a DNA-methylation-driven gene in lung squamous cell carcinoma
Gaofeng Liang, Jinxian He, Tian Chen, et al.
Annals of Medicine (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Gaofeng Liang, Jinxian He, Tian Chen, et al.
Annals of Medicine (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 1